The amyloid precursor protein gene: A neuropeptide gene with diverse functions in the central nervous system

Neuropeptides

Volumn 31, Issue 6, 1997, Pages 523-535

  Panegyres, P K ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; DOWN SYNDROME; GENE FUNCTION; GENE LOCATION; GENE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW;

EID: 0031443264     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(97)90000-7     Document Type: Review

References (179)

1. Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitsch Psych Psychisch-Gerichtichliche Med 1907; LXIV: 146-148. Translated in: Bick K, Armaducci L, Pepeu G, eds. The Early Story of Alzheimer's Disease. Italy: Livinia Press, 1987: 1-3.
2. Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitsch Psych Psychisch-Gerichtichliche Med 1907; LXIV: 146-148. Translated in: Bick K, Armaducci L, Pepeu G, eds. The Early Story of Alzheimer's Disease. Italy: Livinia Press, 1987: 1-3.
3. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebro-vascular amyloid peptide. Biochem Biophys Res Commun 1984; 120: 885-890.
4. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1988; 82: 4245-4249.
5. Tomlinson BE. Ageing and the dementias. In: Hume Adams J, Duchen LW, eds. Greenfield's Neuropathology, 5th edn. Kent: Edward Arnold, 1992: 1284-1410.
6. Kang J, Lemaire HG, Unterbeck A et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 1987; 325: 733-736.
7. Selkoe DJ, Podlisny MB, Joachim CL et al. B-amyloid precursor protein of Alzheimer disease occurs as 110-135 kilo-dalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci USA 1988; 85: 7341-7345.
8. Neve RL, Finch EA, Dawes LR. Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron 1988; 1: 669-667.
9. Manning RW, Reid CM, Lampe RA, Davis LG. Identification in rodents and other species of an mRNA homologous to the human B-amyloid precursor. Mol Brain Res 1988; 3: 293-298.
10. Anderson JP, Refoldo LM, Wallace W et al. Differential brain expression of the Alzheimer's amyloid precursor protein. EMBO J 1989; 12: 3627-3632.
11. Luo L, Tully T, White K. Human amyloid precursor protein ameliorates behavioural deficit of flies deleted for Appl gene. Neuron 1992; 9: 595-605.
12. Beyreuther K, Pollwein P, Multhaup G et al. Regulation and expression of the Alzheimer's B/A4 amyloid protein precursor in health, disease, and Down's syndrome. Ann NY Acad Sci 1993; 695: 91-102.
13. Esch FS, Keim PS, Beattie EC et al. Cleavage of amyloid B-peptide during constitutive processing of its precursor. Science 1990; 248: 1122-1124.
14. Sisodia SS, Koo EH, Bayreuther K et al. Evidence that B-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 1990; 248: 492-495.
15. Golde TE, Estus S, Usiak M, Younkin LH, Younkin SG. Expression of B amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron 1990; 4: 253-267.
16. Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitor activity. Nature 1988; 331: 530-532.
17. Konig G, Monning U, Czech C et al. Identification and differential expression of a novel alternative splice isoform of the BA4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells. J Biol Chem 1992; 267: 10804-10809.
18. 695 is predominantly produced in rat and human brain. Biochem Biophys Res Commun 1990; 166: 1192-1200.
19. Sandbrink R, Masters CL, Beyreuther K. BA4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons. J Biol Chem 1994; 269: 1510-1517.
20. Ohyagi Y, Takahashi K, Kamegai M, Tabira T. Developmental and differential expression of beta amyloid protein precursor mRNAs in mouse brain. Biochem Biophys Res Commun 1990; 167: 54-60.
21. Sherman CA, Higgins GA. Regulated splicing of the amyloid precursor protein during postnatal development of the rat basal forebrain. Dev Brain Res 1992; 66: 63-69.
22. Ponte P, Gonzalez-Dewhitt P, Schilling J et al. A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors. Nature 1988; 331: 525-527.
23. Tanzi RE, Gusella JF, Watkins PL et al. Protease inhibitor domain encoded by amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 1987; 331: 528-530.
24. Oltersdorf T, Fritz LC, Schenk DB et al. The secreted form of the Alzheimer's precursor protein with the Kunitz domain is protease nexin II. Nature 1989; 341: 144-147.
25. Van Nostrand WE, Cunningham DD. Purification of protease nexin II from human fibroblasts. J Biol Chem 1987; 262: 8508-8514.
26. Van Nostrand WE, Wagner SL, Suzuki M, Choi BH, Farrow JS, Cunningham DD. Protease nexin II, a potent antichymotrypsin, shows identity to amyloid B-protein precursor. Nature 1989; 341: 546-549.
27. Lukiw WJ, Rogaev EI, Wong L, Vaula G, McLachlan DRC, St George Hyslop P. Protein-DNA interactions in the promoter region of the amyloid precursor protein (APP) gene in human neocortex. Mol Brain Res 1994; 22: 121-131.
28. Shivers BD, Hilbich C, Multhaup G, Salbaum M, Beyreuther K, Seeburg PH. Alzheimer's disease amyloidogenic glycoprotein: expression in rat brain suggests a role in cell contact. EMBO J 1988; 7: 1365-1370.
29. Lahiri DK, Robakis NK. The promotor activity of the gene encoding Alzheimer B-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences. Mol Brain Res 1991; 9: 253-257.
30. Salbaum JM, Weidemann A, Lemaire H-G, Masters CL, Beyreuther K. The promoter of Alzheimer's disease amyloid A4 precursor gene. EMBO J 1988; 7: 2807-2813.
31. Wasco W, Bupp K, Magendantz M, Gusella JF, Tanzi RE, Solomon F. Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta-protein precursor. Proc Natl Acad Sci USA 1992; 89: 10758-10762.
32. Wasco W, Gurubhagavatula S, Paradis Md et al. Isolation and characterization of APLP 2 encoding a homologue of the Alzheimer's associated amyloid β protein precursor. Nature Genet 1993; 5: 95-99.
33. Slunt HH, Thinakaran G, von Koch C, Lo ALY, Tanzi RE, Sisodia SS. Expression of a ubiquitous cross-reactive homologue of the mouse β-amyloid precursor protein (APP). J Biol Chem 1994; 269: 2637-2644.
34. Thinakaran G, Kitt CA, Roskams AJI et al. Distribution of an APP homolog, APLP 2, in the mouse olfactory system: a potential role for APLP 2 in axogenesis. J Neurosci 1995; 15: 6314-6326.
35. Palmert MR, Podlisny MB, Witker DS et al. The B-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc Natl Acad Sci USA 1989; 86: 6338-6342.
36. Seubert P, Vigo-Pelfrey C, Esch F et al. Isolation and quantification of soluble Alzheimer's B-peptide from biological fluids. Nature 1992; 359: 325-327.
37. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ. Targeting of cell-surface B-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 1992; 357: 500-502.
38. Haass C, Schlossmacher MG, Hung AY et al. Amyloid B-peptide is produced by cultured cells during normal metabolism. Nature 1992; 359: 322-325.
39. Seubert P, Oltersdorf T, Lee MG et al. Secretion of β-amyloid precursor protein cleaved at the aminoterminus of the β-amyloid peptide. Nature 1993; 361: 260-263.
40. Haass C, Selkoe DJ. Cellular processing of β-amyloid precursor and the genesis of amyloid b-peptide. Cell 1993; 75: 1039-1042.
41. Zhong Z, Higaki J, Wang K, Catalano R, Quon D, Cordell B. Secretion of β-amyloid precursor protein involves multiple cleavage sites. J Biol Chem 1994; 269: 627-632.
42. Roberts SB, Ripellino JA, Ingalls KM, Robakis NK, Felstein KM. Non-amyloidogenic cleavage of the B-amyloid precursor protein by an integral membrane metalloendopeptidase. J Biol Chem 1994; 269: 3111-3116.
43. Oltersdorf T, Ward PJ, Henricksson T et al. The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. J Biol Chem 1990; 265: 4492-4497.
44. Allinquant B, Moya KL, Bouillot C, Prochiantz A. Amyloid precursor protein in cortical neurons: existence of two pools differentially distributed in axons and dendrites and association with cytoskeleton. J Neurosci 1994; 14: 6842-6854.
45. Schubert D, Jin L-W, Saitoh T, Cole G. The regulation of amyloid B protein precursor secretion and its modulatory role in cell adhesion. Neuron 1989; 3: 689-694.
46. Smith CJ, Widon D, Brachet P. Nerve growth factor-induced neuronal differentiation is accompanied by differential splicing of B-amyloid precursor mRNAs in the PC12 cell line. Mol Brain Res 1991; 10: 351-354.
47. Milward EA, Papadopoulos R, Fuller SJ et al. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 1992; 9: 129-137.
48. Yoshikawa K, Aizawa T, Hayashi Y. Degeneration in vitro of post-mitotic neurons over expressing the Alzheimer amyloid protein precursor. Nature 1992; 359: 64-67.
49. Schubert D, Behl C. The expression of beta amyloid protein precursor protects nerve cells from B-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix. Brain Res 1993; 629: 275-282.
50. Small DH, Nurcombe V, Reed G et al. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J Neurosci 1994; 14: 2117-2127.
51. Qiu WQ, Ferreira A, Miller C, Koo EH, Selkoe DJ. Cell-surface B-amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner. J Neurosci 1995; 15: 2157-2167.
52. Jin L-W, Ninomiya H, Rocn J-M et al. Peptides containing the RERMS sequence of amyloid β/A4 protein precursor bind cell surface and promote neurite extension. J Neurosci 1994; 14: 5461-5470.
53. Klier FG, Cole G, Stallcup W, Schubert D. Amyloid B-protein precursor is associated with extracellular matrix. Brain Res 1990; 515: 336-342.
54. Barber K, Enam SA, Bodovitz S, Falduto M, Frail D, Klein WL. Particulate forms of APP in the extracellular milieu of cultured cells. Exp Neurol 1995; 132: 42-53.
55. Narindrasorasak S, Lowery D, Gonzalez-de Whitt P, Poorman RA, Greenberg B, Kisilevsky R. High affinity interactions between the Alzheimer's B-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. J Biol Chem 1991; 266: 12878-12883.
56. Kibbey MC, Jucker M, Weeks BS, Neve RL, Van Nostrand WE, Kleinman HK. β-amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin. Proc Natl Acad Sci USA 1993; 90: 10150-10153.
57. Hung AY, Koo EH, Haass C, Selkoe DJ. Increased expression of β-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage. Proc Natl Acad Sci USA 1992; 89: 9439-9443.
58. Fisher S, Gearhart JD, Oster-Granite ML. Expression of the amyloid precursor protein gene in mouse oocytes and embryos. Proc Natl Acad Sci USA 1991; 88: 1779-1782.
59. Yoshikawa K, Aizawa T, Maruyama K. Neural differentiation increases expression of Alzheimer amyloid protein precursor in murine embryonal carcinoma cells. Biochem Biophys Res Commun 1990; 171: 204-209.
60. Schubert W, Prior R, Weidmann A et al. Localization of Alzheimer BA4 amyloid precursor protein at central and peripheral sites. Brain Res 1991; 563: 184-194.
61. Koo EH, Sisodia SS, Archer DR et al. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA 1990; 87: 1561-1565.
62. Bush AI, Martins RN, Rumble B et al. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem 1990; 265: 15977-15983.
63. Smith RP, Higuchi DA, Broze GJ. Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science 1990; 248: 1126-1128.
64. Guenther J, Nick H, Monard D. A glial-derived neurite-promoting factor with protease inhibitory activity. EMBO J 1985; 4: 1963-1966.
65. Gloor S, Odink K, Guenther J, Nick H, Monard D. A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins. Cell 1986; 47: 687-693.
66. Monard D, Niday E, Limat A, Solomon F. Inhibition of protease activity can lead to neurite extension in neuroblastoma cells. Prog Brain Res 1983; 58: 359-365.
67. Shea TB. Role of glial-derived nexin in neuronal differentiation and in acute brain injury and potential involvement in exacerbation of neurodegeneration in Alzheimer's disease. Brain Res Rev 1995; 20: 171-184.
68. Joseph R, Tsang W, Han E, Saed GM. Neuronal B-amyloid precursor protein gene expression: regulation by aurintricarboxylic acid. Brain Res 1993; 625: 244-255.
69. Smith CJ, Johnson EM, Osborn P, Freman RS, Neveu I, Brachet P. NGF deprivation and neuronal degeneration trigger altered β-amyloid precursor protein expression in the rat superior cervical ganglion in vivo and in vitro. Mol Brain Res 1993; 17: 328-354.
70. Abe K, St George-Hyslop PH, Tanzi RE, Kogure K. Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells. Neurosci Lett 1991; 125: 169-171.
71. Buxbaum JD, Oishi M, Chen HI et al. Cholinergic agonists and interleukin-1 regulate processing and secretion of the Alzheimer B/A4 amyloid protein precursor. Proc Natl Acad Sci USA 1992; 89: 10075-10078.
72. Gray CW, Patel AJ. Regulation of B-amyloid precursor protein isoform mRNAs by transforming growth factor-B1 and interleukin-1 B in astrocytes. Mol Brain Res 1993; 19: 251-256.
73. Forloni G, Demicheli F, Giorgi S, Bendotti C, Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Mol Brain Res 1992; 16: 128-134.
74. Yang F, Jansen L, Friedrichs WE, Buchanan JM, Bowman BH. IL-1B decreases expression of amyloid precursor protein gene in human glioma cells. Biochem Biophys Res Commun 1993; 191: 1014-1019
75. Bush AI, Pettingal WH, Multhaup G et al. Rapid induction of Alzheimer AB amyloid formation by zinc. Science 1994; 265: 1464-1467.
76. Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk DB. Characterization of B-amyloid peptide from human cerebrospinal fluid. J Neurochem 1993; 61: 1965-1968.
77. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW. Structure-activity analyses of β-amyloid peptides: contributions of the B25-35 region to aggregation and neurotoxicity. J Neurochem 1995; 64: 253-265.
78. Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 1990; 250: 279-282.
79. Koh J-Y, Yang LL, Cotman CW β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 1990; 533: 315-320.
80. Shimohigashi Y, Matsumoto H, Takano Y et al. Receptormediated specific biological activity of a β-amyloid protein fragment for NK-1 substance P receptors. Biochem Biophys Res Commun 1993; 193: 624-630.
81. Singh VK, Cheng JF, Leu S-JC. Effect of substance P and protein kinase inhibitors on β-amyloid peptide-induced proliferation of cultured brain cells. Brain Res 1994; 660: 353-356.
82. Mitsuhashi M, Akiaya T, Turk CW, Payan DG. Amyloid β protein substituent peptides do not interact with the substance P receptor expressed in cultured cells. Mol Brain Res 1991; 11: 177-180.
83. Rovero P, Patacchini R, Renzetti AR et al. Interaction of amyloid β protein (25-35) with tachykinin receptors. Neuropeptides 1992; 22: 99-101.
84. Kimura H, Schubert D. Amyloid β-protein activates tachykinin receptors and inositol triphosphate accumulation by synergy with glutamate. Proc Natl Acad Sci USA 1993; 90: 7508-7512.
85. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE. B-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992; 12: 376-389.
86. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the B-amyloid precursor protein. Neuron 1993; 10: 243-254.
87. Harris ME, Hensley K, Butterfield DA, Leedle RA, Carney JM. Direct evidence of oxidative injury produced by the Alzheimer's β-amyloid peptide (1-40) in cultured hippocampal neurons. Exp Neurol 1995; 131: 193-202.
88. Schubert D, Behl C, Brack A, Dargusch R, Sagara Y, Kimura H. Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci USA 1995; 92: 1989-1993.
89. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid βprotein toxicity. Cell 1994; 77: 817-827.
90. Behl C, Davis JB, Klier FG, Schubert D. Amyloid β peptide induces necrosis rather than apoptosis. Brain Res 1994; 645: 253-264.
91. Pike W, Cotman CW. Calretinin-immunoreactive neurons are resistant to β-amyloid toxicity in vitro. Brain Res 1995; 671: 293-298.
92. Takashima A, Noguchi K, Satok, Hoshino T, Imahori K. Tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity. Proc Natl Acad Sci USA 1993; 90: 7789-7793.
93. Maestre GE, Tate BA, Majocha RE, Marotta CA. Membrane surface ruffling in cells that over-express Alzheimer amyloid β/A4 C-terminal peptide. Brain Res 1993; 62: 145-149.
94. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW. Apoptosis is induced by B-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 1993; 90: 7951-7955.
95. Pike CJ, Cummings BJ, Monzani R, Cotman CW. β-amyloid induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzehimer's disease. Neuroscience 1994; 63: 517-531.
96. Meda L, Cassatella MA, Szendrei GI et al. Activation of microglial cells by B-amyloid protein and interferon-γ. Nature 1995; 374: 647-650.
97. Klegeris A, Walker DG, McGeer PL. Activation of macrophages by Alzheimer B amyloid peptide. Biochem Biophys Res Commun 1994; 199: 984-991.
98. Arispe N, Rojas E, Pollard HB. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminium. Proc Natl Acad Sci USA 1993; 90: 567-571.
99. Davidson RM, Shajenko L, Donta TS. Amyloid beta-peptide (ABP) potentiates a nimodipine-sensitive L-type barium conductance in NIE-115 neuroblastoma cells. Brain Res 1994; 643: 324-327.
100. Rabizadeh S, Bitler CM, Butcher LL, Bredesen DE. Expression of the low-affinity nerve growth factor receptor enhances β-amyloid peptide toxicity. Proc Natl Acad Sci USA 1994; 91: 1073-1076.
101. Schwarzman AL, Gregori L, Vitek MP et al. Transthyretin sequesters amyloid β protein and prevents amyloid formation. Proc Natl Acad Sci USA 1994; 91: 8368-8372.
102. Ma J, Yee A, Brewer HB, Das S, Potter H. Amyloid-associated proteins α,-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 1994; 372: 92-94.
103. Strittmatter WJ, Saunders AM, Schmechel D et al. Apolipoprotein E4 high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 1977-1981.
104. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
105. Chong Y-H, Suh Y-H. Aggregation of amyloid precursor proteins by aluminium in vitro. Brain Res 1995; 670: 137-141.
106. Fasman GD, Perczel A, Moore CD. Solubilization of β-amyloid-(1-42)-peptide: reversing the β-shed conformation induced by aluminium with silicates. Proc Natl Acad Sci USA 1995; 92: 369-371.
107. Lorenzo A, Yankner BA. β-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci USA 1994; 91: 12243-12247.
108. Citron M, Teplow DB, Selkoe DJ. Generation of amyloid B protein from its precursor is sequence specific. Neuron 1995; 14: 661-670.
109. Yan SD, Chen X, Fu J et al. Rage and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 1996; 382: 685-691.
110. Card JP, Meade RP, Davis LG. Immunocytochemical localization of the precursor protein for B-amyloid in the rat central nervous system. Neuron 1988; 1: 835-846.
111. Beeson JG, Shelton ER, Chan HW, Gage FH. Differential distribution of amyloid protein precursor immunoreactivity in the rat brain studied by using five different antibodies. J Comp Neurol 1994; 342: 78-96.
112. 677 (L-APP form). J Neurochem 1993; 61: 1553-1556.
113. Solá C, Mengod G, Probst A, Palacios KM. Differential regional and cellular distribution of B-amyloid precursor protein messenger RNAs containing and lacking the Kunitz protease inhibitor domain in the brain of human, rat and mouse. Neuroscience 1993; 53: 267-295.
114. Kawarabayashi T, Shoji M, Yamaguchi H et al. Amyloid b protein precursor accumulatesin swollen neuntes throughout rat brain with aging. Neurosci Lett 1993; 153: 73-76.
115. Nakamura Y, Takeda M, Niigawa H et al. Accumulation of amyloid β-protein precursor (APP) in Purkinje cells and increase of amino-terminal fragments of APP in cerebrum and cerebellum of aged rat brain. Brain Res 1994; 643: 319-323.
116. Muller U, Cristina N, Li ZW et al. Behavioral and anatomical deficits in mice homozygous for a modified B-amyloid precursor protein gene. Cell 1994; 79: 755-765.
117. Flood JF, Roberts E, Sherman MA, Kaplan BE, Morley JE. Topography of a binding site for small amnestic peptides deduced from structure-activity studies: relation to amnestic effect of amyloid B protein. Proc Natl Acad Sci USA 1994; 91: 380-384.
118. Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc Natl Acad Sci USA 1991; 88: 7247-7257.
119. Neve RL, Kammesheidt A, Hohmann CF. Brain transplants of cells expressing the carboxyl-terminal fragment of the Alzheimer amyloid protein precursor cause neuropathology in vivo. Proc Natl Acad Sci USA 1992; 89: 3448-3452.
120. Higgins LS, Holtzman DM, Rabin J, Mobley WC, Cordell B. Transgenic mouse brain histopathology resembles early Alzheimer's disease. Ann Neurol 1994; 35: 598-607.
121. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F B-amyloid precursor protein. Nature 1995; 373: 523-527.
122. Nadler JV. Kainic acid: neurophysiological and neurotoxic actions. Life Sci 1979; 24: 289-300.
123. Siman R, Card JP, Nelson RB, Davis LG. Expression of B-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron 1989; 3: 275-285.
124. Kawarabayashi T, Shoji M, Harigaya Y, Tamaguchi H, Hirai S. Expression of APP in the early stage of brain damage. Brain Res 1991; 563: 334-338.
125. Solá C, Garcia-Ladona FJ, Mengod G, Probst A, Frey P, Palacios JM. Increased levels of the Kunitz protease inhibitor-containing BAPP mRNAs in rat brain following neurotoxic damage. Mol Brain Res 1993; 17: 41-52.
126. Willoughby DA, Johnson SA, Pasinetti GM et al. Amyloid precursor protein mRNA encoding the Kunitz protease inhibitor domain is increased by kainic acid-induced seizures in rat hippocampus. Exp Neurol 1992; 118: 332-339.
127. Brugg B, Dubreuil YL, Huber G, Wollman EE, Delhaye-Bouchaud N, Mariani J. Inflammatory processes induce B-amyloid precursor protein changes in mouse brain. Proc Natl Acad Sci USA 1995; 92: 3032-3035.
128. Panegyres PK. A study of the relationship between brain seizure activity, immediate early genes and the amyloid precursor protein gene. PhD Thesis, University of Cambridge, 1995.
129. Trejo J, Massamiri T, Deng T, Dewji NN, Bayney RM, Brown JH. A direct role for protein kinase C and the transcription factor jun/AP-1 in the regulation of the Alzheimer's B-amyloid precursor protein gene. J Biol Chem 1994; 269: 21682-21690.
130. Iverfeldt K, Walaas SI, Greengard P. Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration. Proc Natl Acad Sci USA 1993; 90: 4146-4150.
131. Wallace W, Ahlers ST, Gotlib J et al. Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. Proc Natl Acad Sci USA 1993; 90: 8712-8716.
132. Shigematsu K, McGeer PL, Walker DG, Ishii T, McGeer EG. Reactive microglia/macrophages phagocytose amyloid precursor protein produced by necrosis following neuronal damage. J Neurosci Res 1992; 31: 443-453.
133. Nakamura Y, Takeda M, Niigawa H, Hariguchi S, Nishimura T. Amyloid B-protein deposition in rat hippocampus lesioned by ibotenic acid injection. Neurosci Lett 1992; 136: 95-98.
134. Pan JB, Monteggia LM, Giordano T. Altered levels and splicing of the amyloid precursor protein in the adult rat hippocampus after treatment with DMSO or retinoic acid. Mol Brain Res 1993; 18: 259-266.
135. Otsuko N, Tamonaga M, Ikeda K. Rapid appearance of B-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res 1991; 568: 35-338.
136. Lewen A, Li GL, Nilsson P, Olsson Y, Hillered L Traumatic brain injury in rat produces changes of B-amyloid precursor protein immunoreactivity. NeuroReport 1995; 6: 357-360.
137. Abe K, Tanzi RE, Kogure K. Selective induction of kunitz type protease inhibitor domain containing amyloid precursor protein mRNA after persistent focal ischemia. Neurosci Lett 1991; 125: 172-174.
138. Stephenson DT, Rash K, Clemens JA. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res 1992; 593: 128-135.
139. Wakita H, Tomimoto H, Akiguchi I, Ohnishi K, Nakamura S, Kimura J. Regional accumulation of amyloid B/A4 protein precursor in the gerbil brain following transient cerebral ischemia. Neurosci Lett 1992; 146: 135-138.
140. Tomimoto H, Wakita H, Akiguchi I, Nakamura S, Kimura J. Temporal profiles of accumulation of amyloid B/A4 protein precursor in the gerbil after graded ischemic stress. J Cereb Blood Flow Metab 1994; 14: 565-573.
141. Palacios G, Mengod G. Tortosa A, Ferrer I, Palacios JM. Increased B-amyloid precursor protein expression in astrocytes in the gerbil hippocampus following ischaemia: association with proliferation of astrocytes. Eur J Neurosci 1995; 7: 501-510.
142. McRae A, Rydolphi KA, Schubert P. Propentosylline depresses amyloid and Alzheimer's CSF microglial antigens after ischaemia. NeuroReport 1994; 5: 1193-1196.
143. Forloni G, Del Bo R, Angeretti N, Smiroldo S, Gabellini N, Vantini G. Nerve growth factor does not influence the expression of β amyloid precursor protein mRNA in rat brain: in vivo and in vitro studies. Brain Res 1993; 620: 292-296.
144. Scott JN, Parhad IM, Clark AW. B-amyloid precursor protein gene is differentially expressed in axotomized sensory and motor systems. Mol Brain Res 1991; 10: 315-325.
145. Alvarez J, Moreno RD, Llanos O et al. Axonal sprouting induced in the sciatic nerve by the amyloid precursor protein (APP) and other antiproteases. Neurosci Lett 1992; 144: 130-134.
146. Alvarez J, Moreno RD, Inestrosa NC. Mitosis of schwann cells and demyelination are induced by the amyloid precursor protein and other protease inhibitors in the rat sciatic nerve. Eur J Neurosci 1995; 7: 152-159.
147. Palacios G, Mengod G, Frey P, Palacios JM. Rapid increase in amyloid precusor protein immunoreactivity in the supraoptic and paraventricular nuclei of the rat hypothalamus after osmotic stress. Neuroreport 1995; 6: 265-268.
148. Nitsch RM, Farber SA, Growdon JH, Wurtman RJ. Release of amyloid β-protein precursor derivatives from hippocampal slices by electrical depolarization. Proc Natl Acad Sci USA 1993; 90: 5191-5193.
149. Zheng H, Jiang M, Trumbauer ME. β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 1995; 81: 525-531.
150. Daigle I, Li C. Apl-1, a Caenorhabditis elagans gene encoding a protein related to the human β-amyloid protein precursor. Proc Natl Acad Sci USA 1993; 90: 12045-12049.
151. Tanzi RE, Gusella JF, Watkins PL et al. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 1987; 235: 880-884.
152. Rumble B, Retallack R, Hilbich C et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 1989; 320: 1446-1452.
153. Goate A, Chartier-Harlin MC, Mullan M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-706.
154. Murrell J, Farlow M, Ghetti B, Benson MD. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 1991; 254: 97-99.
155. Chartier-Harlin MC, Hardy J, Mullan M. Early onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 1991; 353: 844-846.
156. Cai XD, Golde TE, Younkin SG. Excess amyloid beta-protein is released from a mutant amyloid beta protein precursor linked to familial Alzheimer's disease. Science 1993; 259: 514-516.
157. Citron M, Olterdorf T, Haass C et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease causes increased beta amyloid production. Nature 1992; 360: 672-674.
158. Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 1995; 375: 754-760.
159. Levy-Lahad E, Wijsman EM, Nemens E et al. A familial Alzheimer's disease locus on chromosome 1. Science 1995; 269: 970-973.
160. Querfurth HW, Wijsman EM, St George-Hislop PH, Selkoe DJ. β APP mRNA transcription is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family. Mol Brain Res 1995; 28: 319-337.
161. Tanaka S. Liu, Kimura J et al. Age-related changes in the proportion of amyloid precursor protein mRNAs in Alzheimer's disease and other neurological disorders. Mol Brain Res 1992; 15: 303-310.
162. Johnson SA, McNeill T, Cordell B, Finch CE. Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. Science 1990; 2: 854-857.
163. Johnson SA, Pasinetti GM, May PC, Ponte PA, Cordell B, Finch CE. Selective reduction of mRNA for the β-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex of Alzheimer's brains. Exp Neurol 1988; 102: 264-268.
164. Konig G, Salbaum JM, Wiestler D et al. Alternative splicing of the β/A4 amyloid gene of Alzheimer's disease in cortex of control and Alzheimer's disease patients. Mol Brain Res 1991; 9: 259-262.
165. Neve RL, Rogers J, Higgins GA. The Alzheimer amyloid precursor-related transcript lacking the B/A4 sequence is specifically increased in Alzheimer disease brain. Neuron 1990; 5: 329-338.
166. Webster M-T, Francis PT, Procter AW et al. Postmortem brains reveal similar but not identical amyloid precursor protein-like immunoreactivity in Alzheimer compared with other dementias. Brain Res 1994; 644: 347-351.
167. Hyman BT, Wenniger JJ, Tanzi RE. Nonisotopic in situ hybridization of amyloid beta protein precursor in Alzeimer's disease: expression in neurofibrillary tangle bearing neurons and in the microenvironment surrounding senile plaques. Mol Brain Res 1993; 18: 253-258.
168. Tanzi RE, Wenniger JJ, Hyman BT. Cellular specificity and regional distribution of amyloid β protein precursor alternative transcripts are unaltered in Alzheimer hippocampal formation. Mol Brain Res 1993; 18: 246-252.
169. Harrison PJ, Barton AJL, Procter AW, Bowen DM, Pearson RCA. The effects of Alzheimer's disease, other dementias, and premortem course on B-amyloid precursor protein messenger RNA in frontal cortex. J Neurochem 1994; 62: 635-644.
170. Higgins GA, Lewis DA, Bahmanyar S et al. Differential regulation of amyloid-β-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc Natl Acad Sci USA 1988; 85: 1297-1301.
171. Sirinathsinghji DJS, Rigby M, Heavens RP et al. Increased messenger RNA expression of the 695 and 751 amino acid isoforms of the β-amyloid protein precursor in the thalamus of 17-year-old cynomolgus (Macaca fascicularis) monkeys. Neuroscience 1995; 65: 51-57.
172. Cochran E, Bacci B, Chen Y, Patton A, Gambetti P, Antiho-Gambetti L. Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease. Am J Pathol 1991; 139: 485-489.
173. Roberts GW, Gentleman SM, Lynch A, Graham DI. BA4 amyloid protein deposition in brain after head truma. Lancet 1991; 338: 1422-1423.
174. Blumbergs PC, Scott G, Manavis J, Wainwright H, Simpson DA, McLean AJ. Staining of amyloid precursor protein to study damage in mild head injury. Lancet 1994; 344: 1055-1056.
175. Nicoll JAR, Roberts GW, Graham DI. Aplipoprotein E ε 4 allele is
176. Griffin WST, Sheng JG, Gentleman SM, Graham DI, Mrak RE, Roberts GW. Microglial interleukin-1a expression in human head injury: correlations with neuronal and neuritic B-amyloid precursor protein expression. Neurosci Lett 1994; 176: 133-136.
177. Griffin WST, Stanley LC, Ling C et al. Brain interleukin 1 and S100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989; 86: 7611-7615.
178. Sheng JG, Boop FA, Mrak RE, Griffin WST. Increased neuronal B-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1a immunoreactivity. J Neurochem 1994; 62: 1872-1879.
179. Goldgaber D, Harris HW, Hla T et al. Interleukin 1 regulates synthesis of amyloid B-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 1989; 86: 7606-7610.